NCSL podcasts connect you with state legislatures, offering insights from legislative leaders and staff, astute political observers and public policy experts from across the nation. Download or stream our collection today.


A new category of gene therapies is offering life-changing treatments to people with some forms of cancer and other rare disorders. These revolutionary treatments, however, come with a large price tag, sometimes exceeding millions of dollars for a single patient. Often, these costs fall on state Medicaid systems.

On this podcast we discuss how states are dealing with this challenge. One of our guests is Anne Winter, a Medicaid strategist with the national research and consulting firm Health Management Associates. Winter, who has particular expertise in pharmacy benefit management, discusses some of the strategies state are employing.

Our other guest is Colleen Becker, a policy expert at NCSL, who lays out the scope of the challenge facing states.

Colleen Becker, NCSLAnne Winter, Health Management Associates




Additional Resources

Actions: E-mail | Permalink |


Subscribe in a reader


You can add the feed for this podcast to a podcatcher by clicking the RSS link above.

You can subscribe to this podcast by searching for "Our American States" in iTunes, Spotify, Stitcher or the Google Play store. You also can follow the links embedded in the logos below to the appropriate page on iTunes, Spotify, Stitcher or Google Play.

Apple iTunes logo


Spotify logo


Google Play logo